{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:29:32Z","timestamp":1793158172806,"version":"4.5.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2015,3,16]],"date-time":"2015-03-16T00:00:00Z","timestamp":1426464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Ethnic Research Initiative"},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Purpose.<\/jats:title>\n                  <jats:p>Breast cancer is the most common malignancy among women in Lebanon and in Arab countries, with 50% of cases presenting before the age of 50 years.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods.<\/jats:title>\n                  <jats:p>Between 2009 and 2012, 250 Lebanese women with breast cancer who were considered to be at high risk of carrying BRCA1 or BRCA2 mutations because of presentation at young age and\/or positive family history (FH) of breast or ovarian cancer were recruited. Clinical data were analyzed statistically. Coding exons and intron-exon boundaries of BRCA1 and BRCA2 were sequenced from peripheral blood DNA. All patients were tested for BRCA1 rearrangements using multiplex ligation-dependent probe amplification (MLPA). BRCA2 MLPA was done in selected cases.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results.<\/jats:title>\n                  <jats:p>Overall, 14 of 250 patients (5.6%) carried a deleterious BRCA mutation (7 BRCA1, 7 BRCA2) and 31 (12.4%) carried a variant of uncertain significance. Eight of 74 patients (10.8%) aged \u226440 years with positive FH and only 1 of 74 patients (1.4%) aged \u226440 years without FH had a mutated BRCA. Four of 75 patients (5.3%) aged 41\u201350 years with FH had a deleterious mutation. Only 1 of 27 patients aged &amp;gt;50 years at diagnosis had a BRCA mutation. All seven patients with BRCA1 mutations had grade 3 infiltrating ductal carcinoma and triple-negative breast cancer. Nine BRCA1 and 17 BRCA2 common haplotypes were observed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion.<\/jats:title>\n                  <jats:p>Prevalence of deleterious BRCA mutations is lower than expected and does not support the hypothesis that BRCA mutations alone cause the observed high percentage of breast cancer in young women of Lebanese and Arab descent. Studies to search for other genetic mutations are recommended.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1634\/theoncologist.2014-0364","type":"journal-article","created":{"date-parts":[[2015,3,17]],"date-time":"2015-03-17T01:48:24Z","timestamp":1426556904000},"page":"357-364","source":"Crossref","is-referenced-by-count":59,"title":["<i>BRCA1<\/i> and <i>BRCA2<\/i> Mutations in Ethnic Lebanese Arab Women With High Hereditary Risk Breast Cancer"],"prefix":"10.1093","volume":"20","author":[{"given":"Nagi S.","family":"El Saghir","sequence":"first","affiliation":[{"name":"Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie K.","family":"Zgheib","sequence":"additional","affiliation":[{"name":"Departments of Pharmacology and Toxicology, American University of Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein A.","family":"Assi","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia E.","family":"Khoury","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Bidet","sequence":"additional","affiliation":[{"name":"University of Auvergne, Centre Jean Perrin, Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara M.","family":"Jaber","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghid N.","family":"Charara","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rania A.","family":"Farhat","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firas Y.","family":"Kreidieh","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Decousus","sequence":"additional","affiliation":[{"name":"Laboratoire Diagnostique G\u00e9n\u00e9tique et Mol\u00e9culaire, Centre Jean Perrin, Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Romero","sequence":"additional","affiliation":[{"name":"Laboratoire Diagnostique G\u00e9n\u00e9tique et Mol\u00e9culaire, Centre Jean Perrin, Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges M.","family":"Nemer","sequence":"additional","affiliation":[{"name":"Departments of Pharmacology and Toxicology, American University of Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad","family":"Salem","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Shamseddine","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arafat","family":"Tfayli","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaber","family":"Abbas","sequence":"additional","affiliation":[{"name":"Departments of Surgery, American University of Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faek","family":"Jamali","sequence":"additional","affiliation":[{"name":"Departments of Surgery, American University of Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhieddine","family":"Seoud","sequence":"additional","affiliation":[{"name":"Departments of Obstetrics and Gynecology, American University of Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah K.","family":"Armstrong","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center and Department of Gynecology and Obstetrics, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves-Jean","family":"Bignon","sequence":"additional","affiliation":[{"name":"Laboratoire Diagnostique G\u00e9n\u00e9tique et Mol\u00e9culaire, Centre Jean Perrin, Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Uhrhammer","sequence":"additional","affiliation":[{"name":"Laboratoire Diagnostique G\u00e9n\u00e9tique et Mol\u00e9culaire, Centre Jean Perrin, Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,3,16]]},"reference":[{"key":"2021122309354712400_B1","volume-title":"GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012"},{"key":"2021122309354712400_B2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ijsu.2006.06.015","article-title":"Trends in epidemiology and management of breast cancer in developing Arab countries: A literature and registry analysis","volume":"5","author":"El Saghir","year":"2007","journal-title":"Int J Surg"},{"key":"2021122309354712400_B3","doi-asserted-by":"crossref","first-page":"491","DOI":"10.7150\/jca.9216","article-title":"Outcome of breast cancer patients treated outside of clinical trials","volume":"5","author":"El Saghir","year":"2014","journal-title":"J Cancer"},{"key":"2021122309354712400_B4","doi-asserted-by":"crossref","first-page":"e417","DOI":"10.1016\/S1470-2045(13)70165-7","article-title":"Breast cancer in Arab populations: Molecular characteristics and disease management implications","volume":"14","author":"Chouchane","year":"2013","journal-title":"Lancet Oncol"},{"key":"2021122309354712400_B5","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.annepidem.2003.12.002","article-title":"Cancer incidence in postwar Lebanon: Findings from the first national population-based registry, 1998","volume":"14","author":"Shamseddine","year":"2004","journal-title":"Ann Epidemiol"},{"key":"2021122309354712400_B6","volume-title":"Lebanese national cancer registry"},{"key":"2021122309354712400_B7","first-page":"4","article-title":"Cancer in Lebanon: Analysis of 10,220 cases from the American University of Beirut Medical Center","volume":"46","author":"El Saghir","year":"1998","journal-title":"J Med Liban"},{"issue":"suppl 1","key":"2021122309354712400_B8","first-page":"S2","article-title":"Epidemiology and prognosis of breast cancer in young women","volume":"5","author":"Assi","year":"2013","journal-title":"J Thorac Dis"},{"key":"2021122309354712400_B9","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/1471-2407-6-194","article-title":"Effects of young age at presentation on survival in breast cancer","volume":"6","author":"El Saghir","year":"2006","journal-title":"BMC Cancer"},{"key":"2021122309354712400_B10","doi-asserted-by":"crossref","first-page":"928562","DOI":"10.1155\/2013\/928562","article-title":"A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer","volume":"2013","author":"Karami","year":"2013","journal-title":"Biomed Res Int"},{"key":"2021122309354712400_B11","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.7314\/APJCP.2013.14.10.5671","article-title":"Lack of association of BRCA1 and BRCA2 variants with breast cancer in an ethnic population of Saudi Arabia, an emerging high-risk area","volume":"14","author":"Hasan","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"2021122309354712400_B12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10549-006-9303-z","article-title":"BRCA1 and BRCA2 status in a central Sudanese series of breast cancer patients: Interactions with genetic, ethnic and reproductive factors","volume":"102","author":"Awadelkarim","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"2021122309354712400_B13","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s10038-007-0195-5","article-title":"Contribution of the BRCA1 and BRCA2 mutations to breast cancer in Tunisia","volume":"52","author":"Troudi","year":"2007","journal-title":"J Hum Genet"},{"key":"2021122309354712400_B14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7150\/ijms.5.197","article-title":"BRCA1 mutations in Algerian breast cancer patients: High frequency in young, sporadic cases","volume":"5","author":"Uhrhammer","year":"2008","journal-title":"Int J Med Sci"},{"key":"2021122309354712400_B15","doi-asserted-by":"crossref","first-page":"60","DOI":"10.7150\/ijms.5014","article-title":"Mutation screening of the BRCA1 gene in early onset and familial breast\/ovarian cancer in Moroccan population","volume":"10","author":"Laraqui","year":"2013","journal-title":"Int J Med Sci"},{"key":"2021122309354712400_B16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1756-9966-29-82","article-title":"Presymptomatic breast cancer in Egypt: Role of BRCA1 and BRCA2 tumor suppressor genes mutations detection","volume":"29","author":"Ibrahim","year":"2010","journal-title":"J Exp Clin Cancer Res"},{"key":"2021122309354712400_B17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1897-4287-10-7","article-title":"Prevalance of BRCA1 and BRCA2 mutations in familial breast cancer patients in Lebanon","volume":"10","author":"Jalkh","year":"2012","journal-title":"Hered Cancer Clin Pract"},{"key":"2021122309354712400_B18","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1054\/bjoc.2000.1407","article-title":"Prevalence and penetrance off BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases","volume":"83","author":"Anglian Breast Cancer Study Group","year":"2000","journal-title":"Br J Cancer"},{"key":"2021122309354712400_B19","volume-title":"Breast Cancer Information Core: An open access on-line breast cancer mutation data base"},{"key":"2021122309354712400_B20","volume-title":"The UMD-BRCA1 mutations database"},{"key":"2021122309354712400_B21","volume-title":"The UMD-BRCA2 mutations database"},{"key":"2021122309354712400_B22","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1200\/JCO.2011.39.8545","article-title":"BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: A report from the Australian Ovarian Cancer Study Group","volume":"30","author":"Alsop","year":"2012","journal-title":"J Clin Oncol"},{"key":"2021122309354712400_B23","doi-asserted-by":"crossref","first-page":"E1200","DOI":"10.1002\/humu.21202","article-title":"Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: The WECARE study","volume":"31","author":"Borg","year":"2010","journal-title":"Hum Mutat"},{"key":"2021122309354712400_B24","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/ejhg.2014.16","article-title":"Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes","volume":"22","author":"Cast\u00e9ra","year":"2014","journal-title":"Eur J Hum Genet"},{"key":"2021122309354712400_B25","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1158\/1055-9965.EPI-13-1279","article-title":"Variation in mutation spectrum partly explains regional differences in the breast cancer risk of female BRCA mutation carriers in the Netherlands","volume":"23","author":"Vos","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2021122309354712400_B26","first-page":"700","article-title":"BRCA1 and BRCA2 mutations in breast cancer patients from Saudi Arabia","volume":"23","author":"El-Harith","year":"2002","journal-title":"Saudi Med J"},{"key":"2021122309354712400_B27","first-page":"45","article-title":"BRCA1 gene molecular alterations in Omani breast cancer patients","volume":"1","author":"Al-Moundhri","year":"2013","journal-title":"Gulf J Oncolog"},{"key":"2021122309354712400_B28","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s11033-011-0829-8","article-title":"Hereditary breast cancer in Middle Eastern and North African (MENA) populations: Identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population","volume":"39","author":"Mahfoudh","year":"2012","journal-title":"Mol Biol Rep"},{"key":"2021122309354712400_B29","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1155\/2010\/585278","article-title":"BRCA1 and BRCA2 germline mutations screening in Algerian breast\/ovarian cancer families","volume":"28","author":"Cherbal","year":"2010","journal-title":"Dis Markers"},{"key":"2021122309354712400_B30","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2407-7-14","article-title":"A novel BRCA-1 mutation in Arab kindred from east Jerusalem with breast and ovarian cancer","volume":"7","author":"Kadouri","year":"2007","journal-title":"BMC Cancer"},{"key":"2021122309354712400_B31","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00008469-200508000-00008","article-title":"Differences in the characteristics of families with BRCA1 and BRCA2 mutations in Israel","volume":"14","author":"Rennert","year":"2005","journal-title":"Eur J Cancer Prev"},{"key":"2021122309354712400_B32","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa1400382","article-title":"Breast-cancer risk in families with mutations in PALB2","volume":"371","author":"Antoniou","year":"2014","journal-title":"N Engl J Med"},{"key":"2021122309354712400_B33","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","article-title":"Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2","volume":"302","author":"King","year":"2003","journal-title":"Science"},{"key":"2021122309354712400_B34","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00439-011-1003-z","article-title":"Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers","volume":"130","author":"Im","year":"2011","journal-title":"Hum Genet"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.2014-0364","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.2014-0364","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/20\/4\/357\/41870930\/oncolo_20_4_357.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/20\/4\/357\/41870930\/oncolo_20_4_357.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T02:54:14Z","timestamp":1640314454000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/20\/4\/357\/6399000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,16]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,3,16]]},"published-print":{"date-parts":[[2015,4,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2014-0364","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,4,1]]},"published":{"date-parts":[[2015,3,16]]}}}